US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biotechnology

59.57

+1.061.82%

Number of Gainers:404

Number of Losers:127

Number of Flat:9

PE:- -

High:59.63

Open:58.50

Low:58.50

Close:58.50

Volume:958.63M

Turnover:15.65B

Market Cap:1.55T

Float Cap:1.39T

Loading ...

D.Western Therapeutics Institute Reports Decline in H1 2025 Financials

Savelend Q2 EBITDA Loss Narrows To Sek 0.4 Million

Relief Therapeutics Advances Pipeline and Explores AI-driven Expansion

Masfen Securities Acquires Substantial Stake in Pacific Edge Limited

Kodiak Sciences Inc : JP Morgan Raises to Neutral From Underweight

THOMSON REUTERS

Enliven Therapeutics Reports Positive Trial Results and Strong Financials

Aura Biosciences Advances Clinical Trials and Strengthens Finances

Kezar Life Sciences Advances in Autoimmune Hepatitis Trials

Savara Inc. Reports Increased Loss Amid Ongoing R&D Investments

Tourmaline Bio Reports Positive Trial Results and Strong Cash Position

Applied Therapeutics Advances Pipeline Amid Financial Challenges

Moleculin Biotech Reports Q2 2025 Financial Results

Jasper Therapeutics Reports Promising Q2 2025 Results

Kamada Ltd. Reports Strong 2025 Financial Growth

Argenica Therapeutics Receives Full Clinical Hold Letter from FDA Regarding Investigational New Drug Application

MT Newswires Live

Biogen : Piper Sandler Raises Target Price to $118 From $115

THOMSON REUTERS

CSL (CMXHF) Gets a Buy from UBS

CFO Charles W. Newton Reports Disposal of Lyell Immunopharma Common Shares

Christopher Gibson, CEO, Reports Disposal of Recursion Pharmaceuticals Inc. Common Shares

Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB) and Accuray (ARAY)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4139/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4139","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4139\",,,,,undefined,":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":59.56654,"timestamp":1755115199999,"preClose":58.503128,"halted":0,"volume":958631278,"delay":0,"changeRate":0.018177,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.063412,"latestTime":"08-13 16:00:00 EDT","open":58.503036,"high":59.631737,"low":58.502995,"amount":15645134169.045805,"amplitude":0.019294,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1755178200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.968524,"peRate":-105.007267,"turnoverRate":0.031222,"increases":404,"decrements":127,"flats":8,"marketCap":1552786905282.5,"floatMarketCap":1387135833407.4668},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4139\",,,,,undefined,":{"symbol":"BK4139","high":59.631737,"amplitude":0.019294,"preClose":58.503128,"low":58.502995,"pbRate":"5.968524","latestPrice":59.56654,"volume":958631278,"delay":0,"open":58.503036,"prevYearClose":54.762566,"prevWeekClose":57.9806,"prevMonthClose":57.7408,"prevQuarterClose":55.2146,"fiveDayClose":57.6165,"twentyDayClose":57.6704,"sixtyDayClose":53.4543,"secType":"PLATE","market":"US","turnoverRate":0.031222,"peRate":-105.007267,"marketCap":1552786905282.5,"floatMarketCap":1387135833407.4668,"timestamp":1755115199999,"nameCN":"Biotechnology"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4139\",,,,undefined,":{"bkCode":"BK4139","up":404,"down":127,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4139\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559493738","title":"D.Western Therapeutics Institute Reports Decline in H1 2025 Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2559493738","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559493738?lang=en_us&edition=fundamental","pubTime":"2025-08-14 15:10","pubTimestamp":1755155417,"startTime":"0","endTime":"0","summary":"An update from D.Western Therapeutics Institute ( ($JP:4576) ) is now available. D.Western Therapeutics Institute reported a decrease in net sales ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/d-western-therapeutics-institute-reports-decline-in-h1-2025-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/d-western-therapeutics-institute-reports-decline-in-h1-2025-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2559932683","title":"Savelend Q2 EBITDA Loss Narrows To Sek 0.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559932683","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559932683?lang=en_us&edition=fundamental","pubTime":"2025-08-14 14:50","pubTimestamp":1755154203,"startTime":"0","endTime":"0","summary":"Aug 14 (Reuters) - SaveLend Group AB ::*Q2 EBITDA AMOUNTED TO SEK -0.35 MILLION (SEK -1.56 MILLION)*Q2  NET SALES SEK 26.75 MILLION  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 14-AUG-202506:28:02.173 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nRSD1Zz8sK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","YTENQ"],"gpt_icon":0},{"id":"2559193141","title":"Relief Therapeutics Advances Pipeline and Explores AI-driven Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2559193141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559193141?lang=en_us&edition=fundamental","pubTime":"2025-08-14 13:36","pubTimestamp":1755149761,"startTime":"0","endTime":"0","summary":"RELIEF THERAPEUTICS Holding ( ($CH:RLF) ) just unveiled an update. Relief Therapeutics has released its 2025 half-year report, highlighting signifi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/relief-therapeutics-advances-pipeline-and-explores-ai-driven-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/relief-therapeutics-advances-pipeline-and-explores-ai-driven-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2559931171","title":"Masfen Securities Acquires Substantial Stake in Pacific Edge Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2559931171","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559931171?lang=en_us&edition=fundamental","pubTime":"2025-08-14 13:12","pubTimestamp":1755148332,"startTime":"0","endTime":"0","summary":"An update from Pacific Edge Limited ( ($PFGTF) ) is now available. Masfen Securities Limited, along with Peter Masfen, Anatole Masfen, and Raphael ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/masfen-securities-acquires-substantial-stake-in-pacific-edge-limited?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/masfen-securities-acquires-substantial-stake-in-pacific-edge-limited?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PFGTF","PEB.NZ","BK8033","BK4139"],"gpt_icon":0},{"id":"2559993951","title":"Kodiak Sciences Inc : JP Morgan Raises to Neutral From Underweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2559993951","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559993951?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:54","pubTimestamp":1755147250,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nFWN3U525A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"2559939978","title":"Enliven Therapeutics Reports Positive Trial Results and Strong Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2559939978","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559939978?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:31","pubTimestamp":1755145903,"startTime":"0","endTime":"0","summary":"Enliven Therapeutics, Inc. ( ($ELVN) ) has released its Q2 earnings. Here is a breakdown of the information Enliven Therapeutics, Inc. presented to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/enliven-therapeutics-reports-positive-trial-results-and-strong-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/enliven-therapeutics-reports-positive-trial-results-and-strong-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2559391199","title":"Aura Biosciences Advances Clinical Trials and Strengthens Finances","url":"https://stock-news.laohu8.com/highlight/detail?id=2559391199","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559391199?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:31","pubTimestamp":1755145891,"startTime":"0","endTime":"0","summary":"Aura Biosciences Inc ( ($AURA) ) has released its Q2 earnings. Here is a breakdown of the information Aura Biosciences Inc presented to its investo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aura-biosciences-advances-clinical-trials-and-strengthens-finances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aura-biosciences-advances-clinical-trials-and-strengthens-finances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AURA","BK4139"],"gpt_icon":0},{"id":"2559093961","title":"Kezar Life Sciences Advances in Autoimmune Hepatitis Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2559093961","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559093961?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:31","pubTimestamp":1755145870,"startTime":"0","endTime":"0","summary":"Kezar Life Sciences ( ($KZR) ) has released its Q2 earnings. Here is a breakdown of the information Kezar Life Sciences presented to its investors....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kezar-life-sciences-advances-in-autoimmune-hepatitis-trials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kezar-life-sciences-advances-in-autoimmune-hepatitis-trials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KZR","BK4139"],"gpt_icon":0},{"id":"2559939117","title":"Savara Inc. Reports Increased Loss Amid Ongoing R&D Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2559939117","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559939117?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:30","pubTimestamp":1755145846,"startTime":"0","endTime":"0","summary":"Savara ( ($SVRA) ) has released its Q2 earnings. Here is a breakdown of the information Savara presented to its investors. Savara Inc. is a clinica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/savara-inc-reports-increased-loss-amid-ongoing-rd-investments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/savara-inc-reports-increased-loss-amid-ongoing-rd-investments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SVRA","BK4139"],"gpt_icon":0},{"id":"2559399779","title":"Tourmaline Bio Reports Positive Trial Results and Strong Cash Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2559399779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559399779?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:30","pubTimestamp":1755145827,"startTime":"0","endTime":"0","summary":"Tourmaline Bio, Inc. ( ($TRML) ) has released its Q2 earnings. Here is a breakdown of the information Tourmaline Bio, Inc. presented to its investo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tourmaline-bio-reports-positive-trial-results-and-strong-cash-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tourmaline-bio-reports-positive-trial-results-and-strong-cash-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","TRML"],"gpt_icon":0},{"id":"2559893967","title":"Applied Therapeutics Advances Pipeline Amid Financial Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2559893967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559893967?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:30","pubTimestamp":1755145815,"startTime":"0","endTime":"0","summary":"Applied Therapeutics ( ($APLT) ) has released its Q2 earnings. Here is a breakdown of the information Applied Therapeutics presented to its investo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/applied-therapeutics-advances-pipeline-amid-financial-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/applied-therapeutics-advances-pipeline-amid-financial-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4139","BK4539"],"gpt_icon":0},{"id":"2559493679","title":"Moleculin Biotech Reports Q2 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2559493679","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559493679?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:19","pubTimestamp":1755145181,"startTime":"0","endTime":"0","summary":"Moleculin Biotech ( ($MBRX) ) has released its Q2 earnings. Here is a breakdown of the information Moleculin Biotech presented to its investors. Mo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/moleculin-biotech-reports-q2-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/moleculin-biotech-reports-q2-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MBRX","BK4139"],"gpt_icon":0},{"id":"2559936787","title":"Jasper Therapeutics Reports Promising Q2 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2559936787","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559936787?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:19","pubTimestamp":1755145169,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics, Inc. ( ($JSPR) ) has released its Q2 earnings. Here is a breakdown of the information Jasper Therapeutics, Inc. presented to i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-reports-promising-q2-2025-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jasper-therapeutics-reports-promising-q2-2025-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JSPR"],"gpt_icon":0},{"id":"2559936212","title":"Kamada Ltd. Reports Strong 2025 Financial Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2559936212","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559936212?lang=en_us&edition=fundamental","pubTime":"2025-08-14 12:11","pubTimestamp":1755144677,"startTime":"0","endTime":"0","summary":"Kamada Ltd ( ($KMDA) ) has released its Q2 earnings. Here is a breakdown of the information Kamada Ltd presented to its investors. Kamada Ltd. is a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kamada-ltd-reports-strong-2025-financial-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kamada-ltd-reports-strong-2025-financial-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","KMDA"],"gpt_icon":0},{"id":"2559632936","title":"Argenica Therapeutics Receives Full Clinical Hold Letter from FDA Regarding Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2559632936","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559632936?lang=en_us&edition=fundamental","pubTime":"2025-08-14 11:50","pubTimestamp":1755143439,"startTime":"0","endTime":"0","summary":"Argenica Therapeutics  received a full clinical hold letter from the US Food and Drug Administration  on the reasons for the imposed clinical hold and the information required to lift the hold regarding its investigational new drug application, enable clinical trials of the ARG-007 drug candidate in acute ischaemic stroke in the US, according to a Thursday Australian bourse filing.The regulator requested additional information to ensure that the proposed trial dosing for a US trial can be achieved safely in humans, and the firm plans to use its phase two acute ischaemic stroke trial safety data, which will be available in September, as part of its response.The FDA also requested Argenica to conduct three additional in vitro cell culture studies with clinical research organizations to address identified gaps in data. It also asked the firm to include more detail on the phase one data in the investigational brochure.The firm's shares fell 1% in recent trading on Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AGN.AU","BK7096","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2559350429","title":"Biogen : Piper Sandler Raises Target Price to $118 From $115","url":"https://stock-news.laohu8.com/highlight/detail?id=2559350429","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559350429?lang=en_us&edition=fundamental","pubTime":"2025-08-14 11:31","pubTimestamp":1755142301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nFWN3U5243:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","IE00B19Z9Z06.USD","BIIB","LU0889565916.HKD","LU0234570918.USD","BK4139","IE00B894F039.SGD","BK4585","BK4533","LU0109394709.USD","BK4588","LU0320765992.SGD","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2559693339","title":"CSL (CMXHF) Gets a Buy from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2559693339","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559693339?lang=en_us&edition=fundamental","pubTime":"2025-08-14 09:35","pubTimestamp":1755135312,"startTime":"0","endTime":"0","summary":"UBS analyst Laura Sutcliffe maintained a Buy rating on CSL today and set a price target of A$310.00. The company’s shares closed last Monday at $16...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/csl-cmxhf-gets-a-buy-from-ubs-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/csl-cmxhf-gets-a-buy-from-ubs-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0728928796.USD","BK4139","BK4086","CSL","SGXZ23171101.USD","LU1169590202.USD","SG9999004303.SGD","LU1169589451.USD","CMXHF"],"gpt_icon":0},{"id":"2559371938","title":"CFO Charles W. Newton Reports Disposal of Lyell Immunopharma Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559371938","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559371938?lang=en_us&edition=fundamental","pubTime":"2025-08-14 09:06","pubTimestamp":1755133591,"startTime":"0","endTime":"0","summary":"Charles W. Newton, the Chief Financial Officer of Lyell Immunopharma Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 13, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDLZDvBD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","LYEL","BK4505"],"gpt_icon":0},{"id":"2559493837","title":"Christopher Gibson, CEO, Reports Disposal of Recursion Pharmaceuticals Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2559493837","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559493837?lang=en_us&edition=fundamental","pubTime":"2025-08-14 09:03","pubTimestamp":1755133434,"startTime":"0","endTime":"0","summary":"Christopher Gibson, Chief Executive Officer and Director of Recursion Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 13, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDLbS05hf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4611","BK4539","BK4139","BK4609","RXRX"],"gpt_icon":1},{"id":"2559382419","title":"Analysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB) and Accuray (ARAY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2559382419","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559382419?lang=en_us&edition=fundamental","pubTime":"2025-08-14 08:50","pubTimestamp":1755132611,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Solid Biosciences (SLDB – Research Report) and Accur...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solid-biosciences-sldb-and-accuray-aray-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solid-biosciences-sldb-and-accuray-aray-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SLDB","ARAY","BK4082","BK4137","HCSG"],"gpt_icon":0}],"pageSize":20,"totalPage":141,"pageCount":1,"totalSize":2805,"code":"91000000","status":"200"}]}}